LakeShore Biopharma Co. L...
(LSB)
undefined
undefined%
At close: undefined
2.50
0.00%
After-hours Dec 13, 2024, 02:44 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | 573.42M | 687.20M | 502.95M | 257.02M |
Cost of Revenue | 117.69M | 153.36M | 117.07M | 59.66M |
Gross Profit | 455.73M | 533.84M | 385.88M | 197.36M |
Operating Income | -445.83M | -139.38M | -549.18K | -125.85M |
Interest Income | - | - | - | - |
Pretax Income | -455.19M | -144.35M | -545.73K | -174.37M |
Net Income | -433.46M | -145.48M | -545.73K | -191.83M |
Selling & General & Admin | 428.09M | 333.32M | 549.18K | 208.33M |
Research & Development | 302.80M | 318.70M | 211.22M | 94.39M |
Other Expenses | 170.67M | -199.45K | -2.41M | -22.36M |
Operating Expenses | 901.56M | 647.15M | 549.18K | 319.68M |
Interest Expense | 44.34M | 30.86M | 2.72M | 29.69M |
Selling & Marketing Expenses | 280.45M | 251.56M | 165.72M | 69.44M |
Cost & Expenses | 1.02B | 800.51M | 549.18K | 379.33M |
Income Tax | -21.73M | 1.13M | 4.94M | 17.45M |
Shares Outstanding (Basic) | 106.92M | 77.42M | 29.50M | 28.75M |
Shares Outstanding (Diluted) | 106.92M | 77.42M | 29.50M | 28.75M |
EPS (Basic) | -4.05 | -1.88 | -0.02 | -6.67 |
EPS (Diluted) | -4.05 | -1.88 | -0.02 | -6.67 |
EBITDA | -368.66M | -76.80M | -67.20M | -116.78M |
Depreciation & Amortization | 42.19M | 36.69M | 31.15M | 27.91M |